The average one-year price target for AvroBio (NASDAQ:AVRO) has been revised to 3.74 / share. This is an increase of 12.82% from the prior estimate of 3.32 dated August 31, 2023. The price target is ...
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has AVROBIO, Inc. (AVRO) been one of those stocks this year? A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results